You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Express Scripts
Merck
Mallinckrodt
McKesson

Last Updated: July 10, 2020

DrugPatentWatch Database Preview

NIMODIPINE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

US ANDA Litigation and Generic Entry Outlook for Nimodipine

A generic version of NIMODIPINE was approved as nimodipine by HERITAGE PHARMS INC on May 2nd, 2007.

  Start Trial

Drug patent expirations by year for NIMODIPINE
Drug Prices for NIMODIPINE

See drug prices for NIMODIPINE

Recent Clinical Trials for NIMODIPINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ascension South East MichiganPhase 4
University of TwentePhase 2
Rijnstate HospitalPhase 2

See all NIMODIPINE clinical trials

Pharmacology for NIMODIPINE
Medical Subject Heading (MeSH) Categories for NIMODIPINE

US Patents and Regulatory Information for NIMODIPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bionpharma Inc NIMODIPINE nimodipine CAPSULE;ORAL 076740-001 Jan 17, 2008 AB RX No Yes   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Inc NIMODIPINE nimodipine CAPSULE;ORAL 077067-001 Apr 17, 2007 DISCN No No   Start Trial   Start Trial   Start Trial
Heritage Pharms Inc NIMODIPINE nimodipine CAPSULE;ORAL 077811-001 May 2, 2007 AB RX No No   Start Trial   Start Trial   Start Trial
Sofgen Pharms NIMODIPINE nimodipine CAPSULE;ORAL 201832-001 Jul 24, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Thepharmanetwork Llc NIMODIPINE nimodipine CAPSULE;ORAL 090103-001 Apr 7, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Express Scripts
Merck
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.